These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6376259)

  • 1. [Topical treatment of genital herpes simplex with a pregnene derivative].
    Macotela E; Suárez-de la Torre RS; Hernández-Flores MF; Campos-Macías P
    Gac Med Mex; 1984 Feb; 120(2):59-60. PubMed ID: 6376259
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical heparin for recurrent genital herpes simplex virus infections. A proposed model for subsequent therapeutic trials.
    Grossman JH; Thonnard-Neumann E
    J Reprod Med; 1985 Sep; 30(9):675-6. PubMed ID: 3903156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tromantadine in the treatment of genital herpes. A double-blind placebo controlled study.
    Petersen CS; Weismann K; Avnstorp C; Rasmussen LP; Fogh H; Tikjøb G
    Dan Med Bull; 1993 Sep; 40(4):506-7. PubMed ID: 8222773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs today.
    Goldwater PN
    N Z Med J; 1984 Dec; 97(769):852-4. PubMed ID: 6392956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tromantadine hydrochloride in the treatment of herpes genitalis. A double-blind controlled study].
    Altomare GF; Polenghi MM; Pigatto PD; Oberhauser V
    G Ital Dermatol Venereol; 1985; 120(4):XLI-XLVI. PubMed ID: 3899919
    [No Abstract]   [Full Text] [Related]  

  • 6. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betadine for herpes simplex infection.
    Waters LJ; Barton SE; Boag FC
    Int J STD AIDS; 2006 Dec; 17(12):854-5. PubMed ID: 17212866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment to: topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions Al-Waili NS Med Sci Monit, 2004; 10(8): MT94-MT98.
    Carilli S
    Med Sci Monit; 2005 Dec; 11(12):LE24. PubMed ID: 16319801
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
    J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course therapy for recurrent genital herpes and herpes labialis.
    Spruance S; Aoki FY; Tyring S; Stanberry L; Whitley R; Hamed K
    J Fam Pract; 2007 Jan; 56(1):30-6. PubMed ID: 17217895
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with Hevizos ointment].
    Makleit L
    Acta Pharm Hung; 1993 Jul; 63(4):181-7. PubMed ID: 8379333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical acyclovir for herpes simplex.
    Med Lett Drugs Ther; 1982 Jun; 24(611):55-6. PubMed ID: 7087887
    [No Abstract]   [Full Text] [Related]  

  • 17. Arabinosyladenine monophosphate in genital herpes: a double-blind, placebo-controlled study.
    Hatcher VA; Friedman-Kien AE; Marcus EL; Klein RJ
    Antiviral Res; 1982 Oct; 2(5):283-90. PubMed ID: 6185089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
    Leone PA; Trottier S; Miller JM
    Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of acyclovir in the treatment of recurring herpes labialis, genitalis and acute herpes zoster.
    Peralta S; Ribisi La Spina AM; Pirrotta P; Collura D; Formica P; Tinnirello D; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1117-8. PubMed ID: 16312797
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapies of genital herpes simplex in women].
    Davidi O; Dicker D; Chen R; Ben Rafael Z
    Harefuah; 1999 May; 136(10):803-5. PubMed ID: 10955118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.